DUSP3 and breast carcinoma: Guo et al. (2018) showed that miR-1915-3p was upregulated in serum samples of breast cancer patients compared with healthy individuals and that miR-1915-3p might be a diagnostic marker for breast cancer by repression of DUSP3 20.